Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 23, Issue 10, Pages 2566-2572
Publisher
Oxford University Press (OUP)
Online
2012-03-31
DOI
10.1093/annonc/mds055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
- (2011) Cornelis JH van de Velde et al. LANCET
- Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
- (2009) V. Ziller et al. ANNALS OF ONCOLOGY
- Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy
- (2009) P. Hadji et al. ANNALS OF ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer
- (2009) Rowan Chlebowski et al. BREAST
- Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy
- (2009) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Practical guidance for the management of aromatase inhibitor-associated bone loss
- (2008) P. Hadji et al. ANNALS OF ONCOLOGY
- Menopausal symptoms and adjuvant therapy-associated adverse events
- (2008) P Hadji ENDOCRINE-RELATED CANCER
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
- (2008) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial
- (2008) Jack Cuzick et al. LANCET ONCOLOGY
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
- (2008) LANCET ONCOLOGY
- Aromatase Inhibitors: Are There Differences Between Steroidal and Nonsteroidal Aromatase Inhibitors and Do They Matter?
- (2008) W. R. Miller et al. ONCOLOGIST
- Aromatase inhibitor-induced arthralgia: Clinical experience and treatment recommendations
- (2007) R.E. Coleman et al. CANCER TREATMENT REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started